The FDA announced last week a voluntary recall of several high blood pressure and heart failure medications containing valsartan due to a cancerous impurity.
Some valsartan drugs were found to contain N-nitrosodimethylamine (NDMA), a compound that is classified as a probable human carcinogen.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA recalls heart failure, blood pressure drugs due to cancerous contaminant appeared first on MassDevice.
from MassDevice https://ift.tt/2mmMuYZ
Cap comentari:
Publica un comentari a l'entrada